Studies of Benzamide‐ and Thiol‐Based Histone Deacetylase Inhibitors in Models of Oxidative‐Stress‐Induced Neuronal Death: Identification of Some HDAC3‐Selective Inhibitors
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Less stress: We compare three structurally different classes of histone deacetylase (HDAC) inhibitors that contain benzamide, hydroxamate, or thiol groups as the zinc binding group (ZBG) for their ability to protect cortical neurons in culture from cell death induced by oxidative stress. Novel benzamide‐based ligands selectively inhibit HDAC3 but provide no neuroprotection in the HCA–cortical neuron model of oxidative stress.magnified image We compare three structurally different classes of histone deacetylase (HDAC) inhibitors that contain benzamide, hydroxamate, or thiol groups as the zinc binding group (ZBG) for their ability to protect cortical neurons in culture from cell death induced by oxidative stress. This study reveals that none of the benzamide‐based HDAC inhibitors (HDACIs) provides any neuroprotection whatsoever, in distinct contrast to HDACIs that contain other ZBGs. Some of the sulfur‐containing HDACIs, namely the thiols, thioesters, and disulfides present modest neuroprotective activity but show toxicity at higher concentrations. Taken together, these data demonstrate that the HDAC6‐selective mercaptoacetamides that were reported previously provide the best protection in the homocysteic acid model of oxidative stress, thus further supporting their study in animal models of neurodegenerative diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For this reason, RGFP966 (Figure 11) has emerged as the most frequently employed tool for HDAC3 pharmacologic inhibition in biological studies [9, 13, 67, 69–71].”
From Medicinal chemistry advances in targeting class I histone deacetylases (2023) · cites this paper as [71]
Citations
Cites
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Minucci, S., & Pelicci, P. G. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1779 · Cited by 2,200
Acetylation and deacetylation of non-histone proteins
Glozak, M. A., Sengupta, N., Zhang, X., & Seto, E. (2005) · Gene · doi:10.1016/j.gene.2005.09.010 · Cited by 1,584
Histone deacetylase inhibitors: molecular mechanisms of action
Xu, W. S., Parmigiani, R. B., & Marks, P. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210620 · Cited by 1,542
Gregoretti, I., Lee, Y.-M., & Goodson, H. V. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.02.006 · Cited by 1,456
Murphy, T. H., Miyamoto, M., Sastre, A., Schnaar, R. L., & Coyle, J. T. (1989) · Neuron · doi:10.1016/0896-6273(89)90043-3 · Cited by 1,029
(2002) · PubMed · Cited by 732
Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors
Khan, N., Jeffers, M., Kumar, S., Hackett, C., Boldog, F., Khramtsov, N., Qian, X., Mills, E., Berghs, S. C., Carey, N., et al. (2008) · Biochemical Journal · doi:10.1042/bj20070779 · Cited by 713
Kelly, W. K., Richon, V. M., O’Connor, O. A., Curley, T., MacGregor‐Cortelli, B., Tong, W. P., Klang, M. G., Schwartz, L. B., Richardson, S., Rosa, E., et al. (2003) · PubMed · Cited by 624
Rapid Communication: Oxidative Stress Induces Apoptosis in Embryonic Cortical Neurons
Ratan, R. R., Murphy, T. H., & Baraban, J. M. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62010376.x · Cited by 584
Kim, H. J., Rowe, M., Ren, M., Hong, J.-S., Chen, P.-S., & Chuang, D.-M. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.120188 · Cited by 557
Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia
Herman, D., Jenssen, K., Burnett, R., Soragni, E., Perlman, S. L., & Gottesfeld, J. M. (2006) · Nature Chemical Biology · doi:10.1038/nchembio815 · Cited by 442
Ren, M., Leng, Y., Jeong, M., Leeds, P. R., & Chuang, D. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02406.x · Cited by 378
Histone deacetylase inhibitors: discovery and development as anticancer agents
Marks, P. A., & Dokmanovic, M. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.12.1497 · Cited by 318
Gojo, I., Jiemjit, A., Trepel, J. B., Sparreboom, A., Figg, W. D., Rollins, S., Tidwell, M. L., Greer, J., Chung, E. J., Lee, M.-J., et al. (2007) · Blood · doi:10.1182/blood-2006-05-021873 · Cited by 281
Faraco, G., Pancani, T., Formentini, L., Mascagni, P., Fossati, G., Leoni, F., Moroni, F., & Chiarugi, A. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.027912 · Cited by 255
Class IIa histone deacetylases: regulating the regulators
Martin, M., Kettmann, R., & Dequiedt, F. (2007) · Oncogene · doi:10.1038/sj.onc.1210613 · Cited by 244
Simonini, M. V., Camargo, L. M., Dong, E., Maloku, E., Veldic, M., Costa, E., & Guidotti, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510341103 · Cited by 229
Role of Class I and Class II histone deacetylases in carcinoma cells using siRNA
Glaser, K. B., Li, J., Staver, M. J., Wei, R.-Q., Albert, D. H., & Davidsen, S. K. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.043 · Cited by 218
Histone deacetylase inhibitors as therapeutics for polyglutamine disorders
Butler, R., & Bates, G. P. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1989 · Cited by 214
Kozikowski, A. P., Tapadar, S., Luchini, D. N., Kim, K. H., & Billadeau, D. D. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8002894 · Cited by 189
Self-citationSinn, D.-I., Kim, S.-J., Chu, K., Jung, K.-H., Lee, S.-T., Song, E.-C., Kim, J.-M., Park, D.-K., Kun Lee, S., Kim, M., et al. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.02.006 · Cited by 175
Langley, B., Gensert, J., Beal, M., & Ratan, R. (2005) · Current Drug Target -CNS & Neurological Disorders · doi:10.2174/1568007053005091 · Cited by 168
Self-citationHistone deacetylase inhibitors: possible implications for neurodegenerative disorders
Hahnen, E., Hauke, J., Tränkle, C., Eyüpoglu, I. Y., Wirth, B., & Blümcke, I. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.2.169 · Cited by 165
Petri, S., Kiaei, M., Kipiani, K., Chen, J., Calingasan, N. Y., Crow, J. P., & Beal, M. F. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.09.013 · Cited by 161
Langley, B. C., D’Annibale, M. A., Suh, K., Ayoub, I. A., Tolhurst, A. T., Baştan, B., Yang, L., Ko, B., Fisher, M., Cho, S., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3200-07.2008 · Cited by 154
Self-citationZhang, B., West, E. J., Van, K. C., Gurkoff, G. G., Zhou, J., Zhang, X.-M., Kozikowski, A. P., & Lyeth, B. G. (2008) · Brain Research · doi:10.1016/j.brainres.2008.05.085 · Cited by 144
Self-citationKummar, S., Gutierrez, M. E., Gardner, E. R., Donovan, E. A., Hwang, K., Chung, E. J., Lee, M.-J., Maynard, K., Kalnitskiy, M., Chen, A. P., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0791 · Cited by 140
Chen, Y., Lopez-Sanchez, M., Savoy, D. N., Billadeau, D. D., Dow, G. S., & Kozikowski, A. P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701606b · Cited by 132
Self-citationKozikowski, A. P., Chen, Y., Gaysin, A., Chen, B., D'Annibale, M. A., Suto, C. M., & Langley, B. C. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070178x · Cited by 118
Self-citationStructural Biasing Elements for In-Cell Histone Deacetylase Paralog Selectivity
Wong, J. C., Hong, R., & Schreiber, S. L. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0341440 · Cited by 115
Suzuki, T., Nagano, Y., Kouketsu, A., Matsuura, A., Maruyama, S., Kurotaki, M., Nakagawa, H., & Miyata, N. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049207j · Cited by 109
Konsoula, R., & Jung, M. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.05.001 · Cited by 108
Will broad-spectrum histone deacetylase inhibitors be superseded by more specific compounds?
Karagiannis, T. C., & El‐Osta, A. (2006) · Leukemia · doi:10.1038/sj.leu.2404464 · Cited by 106
Suzuki, T., Kouketsu, A., Itoh, Y., Hisakawa, S., Maeda, S., Yoshida, M., Nakagawa, H., & Miyata, N. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060554y · Cited by 105
Thiol-based SAHA analogues as potent histone deacetylase inhibitors
Suzuki, T., Kouketsu, A., Matsuura, A., Kohara, A., Ninomiya, S.-I., Kohda, K., & Miyata, N. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.03.063 · Cited by 103
Antimalarial Activity of Phenylthiazolyl-Bearing Hydroxamate-Based Histone Deacetylase Inhibitors
Dow, G. S., Chen, Y., Andrews, K. T., Caridha, D., Gerena, L., Gettayacamin, M., Johnson, J. D., Li, Q., Meléndez, V., Obaldía, N., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00439-08 · Cited by 85
Self-citationSmall molecules affecting transcription in Friedreich ataxia
Gottesfeld, J. M. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.06.014 · Cited by 83
Kozikowski, A. P., Chen, Y., Gaysin, A. M., Savoy, D. N., Billadeau, D. D., & Kim, K. H. (2008) · ChemMedChem · doi:10.1002/cmdc.200700314 · Cited by 51
Self-citationSanda, T., Okamoto, T., Uchida, Y., Nakagawa, H., Iida, S., Kayukawa, S., Suzuki, T., Oshizawa, T., Suzuki, T., Miyata, N., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404902 · Cited by 43
Biological Therapies of Autoimmune Diseases
Kourbeti, I. S., & Boumpas, D. T. (2005) · Current Drug Targets - Inflammation & Allergy · doi:10.2174/1568010053622812 · Cited by 32
Hegedus, Z. L., & Nayak, U. (1991) · Archives of Physiology and Biochemistry · doi:10.3109/13813459109145911 · Cited by 18
Kitagawa, Y., Tamura, Y., Shimizu, J., Nakajima‐Takenaka, C., Taniguchi, S., Uesato, S., & Takaki, M. (2007) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0070091 · Cited by 11
Desymmetrization Reactions: A Convenient Synthesis of Aromatic Diamide Diamines
Picard, C., Arnaud, N., & Tisnès, P. (2002) · Synthesis · doi:10.1055/s-2001-16076 · Cited by 11
Research works printed but not linked: 2
- Kelly W. K., 2003, Clin. Cancer Res., 9, 3578
- Furumai R., 2002, Cancer Res., 62, 4916
Cited by
Shen, S., & Kozikowski, A. P. (2016) · ChemMedChem · doi:10.1002/cmdc.201500486 · Cited by 288
Self-citationTherapeutic potential for HDAC inhibitors in the heart
McKinsey, T. A. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134712 · Cited by 230
“Another study reported rapid induction of HDAC3 catalytic activity in neonatal rat ventricular myocytes (NRVMs) treated with lipopolysaccharide (LPS) (79).”
BackgroundInfluentialDevelopment and Therapeutic Implications of Selective Histone Deacetylase 6 Inhibitors
Kalin, J. H., & Bergman, J. A. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4001659 · Cited by 126
Protein Acetylation in the Cardiorenal Axis: The Promise of Histone Deacetylase Inhibitors
Bush, E. W., & McKinsey, T. A. (2010) · Circulation Research · doi:10.1161/circresaha.109.209338 · Cited by 121
Histone deacetylase 3 (HDAC3) inhibitors as anticancer agents: A review
Sarkar, R., Banerjee, S., Amin, S. A., Adhikari, N., & Jha, T. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112171 · Cited by 121
Metadata
- Authors
- Chen, Y., He, R., Chen, Y., D'Annibale, M. A., Langley, B., & Kozikowski, A. P.
- Affiliations
- University of Illinois Chicago (US)
- Cornell University (US)
- Venue
- ChemMedChem
- Publisher
- Wiley
- Published
- 2009-05-04
- Volume
- 4
- Issue
- 5
- Pages
- 842-852
- ISSN
- 1860-7179 (ISSN-L)
- 1860-7187
- OpenAlex
- W1996377862
- Cited by
- 51
- References
- 43
- Citations by year
- 2024: 1 · 2023: 4 · 2021: 3 · 2020: 4 · 2019: 2 · 2018: 6 · 2017: 2 · 2015: 6 · 2014: 4 · 2013: 5 · 2012: 1
- FWCI
- 2.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- ChemMedChem (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Alzheimer's Drug Discovery Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Enzyme function and inhibition
- Keywords
- histone deacetylase inhibitors, zinc-binding groups, oxidative stress, neuronal cell death, neuroprotection, cortical neurons, homocysteic acid, HDAC6, thioesters, disulfides, neurodegenerative diseases
- MeSH terms
- Animals, Benzamides, Carrier Proteins, Cells, Cultured, Enzyme Inhibitors, Histone Deacetylases, Hydroxamic Acids, Models, Biological, Neurons, Sulfhydryl Compounds, Rats, Sprague-Dawley, Apoptosis, Oxidative Stress, Neuroprotective Agents, Protein Isoforms, Rats, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.